Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Dec 6, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
All patients will be examined by a geneticist or a neuropediatric. All clinical data will be collected.
Strategy of the molecular study :
1. for all multiplex and consanguineous families a linkage analysis (loci ATCAY and ABC7 and others AC known genes) will be performed.
2. For all sporadic patients as well as linked multiplex and consanguineous families : sequencing of all coding exons of the gene ATCAY and others AC known genes.
3. For all sporadic male patients and linked families : sequencing of all coding exons of the gene ABC7.
4. For all patients with suggestive features : sequenc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient, child or adult, affected with a congenital or early-onset ataxia defined by:
- • Neurological symptoms observed before age of 2 years.
- • Non progressive cerebellar ataxia observed at the time of examination. Karyotype done or in progress
- Exclusion Criteria:
- • Metabolic disease
- • Specific MRI malformations suggesting a peculiar entity : molar tooth (joubert syndrome), superior vermis dysplasia with cleft (Oligophrenin)
- • Muscle weakness and elevated creatine phosphokinase (CPK)
- • Clearly progressive ataxia.
- • Absence of signature of the informed consent.
- • Absence of affiliation to social security
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Lydie Burglen, PhD
Principal Investigator
Assistance Publique
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials